| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 |
| filingDate |
1992-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1993-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a54b1d571dfa94ce1a500a7f1502f68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84b81d96f20528f23ac5844bce1a8c15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d1b2d66f67ea2afc74f4519ad98a458 |
| publicationDate |
1993-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5214153-A |
| titleOfInvention |
Actinoplanes transformation process anti-hypertensive compound and method of use thereas |
| abstract |
Fermentation of the microorganism Actinoplanes sp. MA6559 (ATCC 53771) in the presence of the Angiotensin II (A II) receptor antagonist <IMAGE> yields a new compound, hydroxylated in the 2-butyl group, which is also an A II antagonist useful in the treatment of hypertension and congestive heart failure and other indications known to respond to A II antagonists. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7872035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5663186-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5663187-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2001274765-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0197807-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1656940-A1 |
| priorityDate |
1992-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |